Burkhart Erin 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed May 20, 2025
Insider Transaction Report
Form 4
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2025-05-19$59.27/sh−996$59,033→ 15,959 total - Sale
Common Stock
2025-05-20$59.31/sh−1,786$105,928→ 14,173 total
Footnotes (1)
- [F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.